Objective: To evaluate the in vivo effects of moderate consumption of red wine, beer and spirits on antioxidants, antioxidant enzymes and antioxidant capacity. Design: Randomized, diet-controlled, cross-over study. Subjects: Twelve apparently healthy, non-smoking middle-aged men were included; 11 of them completed the study. Interventions: Each subject consumed four glasses of red wine, beer, spirits and water (negative control) with evening dinner during four successive periods of 3 weeks, daily at the Institute. The total diet was supplied to the subjects and had essential the same composition during these 12 weeks. Results: Neither the enzyme activities of serum glutathion peroxidase, erythrocyte glutathion reductase and superoxide dismutase nor the plasma concentrations of a-and g-tocopherol, lutein, zeaxantin, b-cryptoxanthin, lycopene and a-carotene were affected. Plasma b-carotene concentrations were decreased after 3 weeks H consumption of red wine, beer and spirits (40 g alcoholaday) as compared to consumption of water, by 15% (P 0.0005), 11% (P 0.010) and 13% (P 0.003), respectively. Also, plasma ascorbic acid was decreased after beer (15%, P 0.004) and spirits (12%, P 0.030), but not after wine consumption. Serum uric acid concentrations were increased after consumption of beer (15%, P`0.0001), spirits (8%, P 0.008) and red wine (9%, P 0.003). The overall serum antioxidant capacity, assessed as Trolox equivalent antioxidant capacity (TEAC), was similar for all treatments. Conclusions: Moderate consumption of red wine, beer and spirits has counteracting effects on plasma antioxidant components, resulting in no signi®cant effect on overall antioxidant status. The effects on antioxidant parameters are largely independent of the type of alcoholic beverage, and probably irrelevant to chronic disease risk.
Introduction
A good antioxidant status may be important for human health and speci®cally for the prevention of chronic diseases such as cancer and coronary heart disease (CHD). Low plasma levels of antioxidants as well as low intakes of dietary antioxidants have been associated with an increased risk for atherosclerotic heart disease (Delport et al, 1998; Diaz et al, 1997) . However, intervention studies with antioxidant vitamins have been less convincing so far (Gaziano, 1999) . Alcohol is preferentially oxidized and may generate excessive amounts of oxygen radicals. Indeed, alcoholic patients have increased concentrations of plasma lipid-peroxides and of serum superoxide dismutase (SOD), indicating oxidative stress (Thome et al, 1997; Topinka et al, 1991) . On the other hand, moderate consumption of alcohol is associated with a decreased risk of coronary heart disease (Kannel and Ellison, 1996; Maclure, 1993) . This triggers the question in what way moderate alcohol consumption affects human antioxidant status.
Red wine has received much attention as potential contributor of antioxidant activity, because of its natural antioxidant compounds, ie polyphenols. The anti-oxidative properties of red wine have been recognized by series of in vitro experiments Frankel et al, 1993; Kerry & Abbey 1997; Paquay et al, 1997) . Also, beer has some anti-oxidative activity in vitro (Fantozzi et al, 1998) .
However, experiments evaluating the in vivo effects of moderate alcohol consumption on human antioxidant status vary greatly in study design, often suffer from methodological shortcomings, resulting in con¯icting results. Diet and smoking both signi®cantly affect antioxidant status in men (Marangon et al, 1998) . Nevertheless, only in one study diet was fully controlled (Kondo et al, 1994) , some included smokers Sharpe et al, 1995; Suzukawa et al, 1994) or lacked information on smoking habits (Gorrinstein et al, 1997; Kondo et al, 1994; Maxwell et al, 1994; Whitehead et al, 1995) . Most studies were restricted to wine consumption De Rijke et al, 1996; Fuhrman et al, 1995; Maxwell et al, 1994; Sharpe et al, 1995; Whitehead et al, 1995) , some included spirits (Kondo et al, 1994; Nigdikar et al, 1998; Suzukawa et al, 1994) and two only focussed on beer consumption Gorrinstein et al, 1997) . Three studies evaluated the acute antioxidant effects of wine consumption on antioxidant status Maxwell et al, 1994; Whitehead et al, 1995) which may have limited relevance in terms of chronic disease prevention. Some of the studies completely relied on indirect measures for antioxidant status Kondo et al, 1994; Maxwell et al, 1994; Whitehead et al, 1995) , and are consequently vulnerable to artefacts (Benzie, 1996) . Therefore we conducted a placebo-controlled randomized trial in which: (1) the total diet was controlled and only nonsmoking volunteers participated; (2) the effects of chronic consumption of red wine, beer and spirits were investigated in one cross-over experiment; and (3) antioxidant status was evaluated by a combination of direct and indirect measures.
Subjects and methods

Subjects
Middle-aged (44 ± 59 y) non-smoking men were recruited from the pool of volunteers of the Institute and through an advertisement in a local newspaper. The protocol was carefully explained to the volunteers and their written informed consent was obtained. Subjects were eligible if they ful®lled the following inclusion criteria: used to consuming 7 ± 28 alcohol-containing beverages per week, having a body mass index between 20 and 28 kgam 2 , having no family history of alcoholism, being healthy as indicated by a general medical questionnaire and a physical examination, and not taking medication on a regular basis. Twelve men entered the study. One subject withdrew due to treatment-related adverse effects. The remaining subjects ®nished the experiment successfully. (See Table 1 for their characteristics.)
Study protocol
The study was a 12-week, randomized, cross-over trial, according to a 464 Latin square design. Daily, all subjects consumed four glasses (40 g of alcohol) of red wine, beer, spirits (Dutch gin), or carbonated mineral water (control) with evening dinner, at the Institute. Each beverage was consumed for 3 weeks. Total diet was controlled, and supplied by the Institute. They consumed all foods at home, except for evening dinner which was served at 18:00 h at the Institute, together with the four glasses of beverage. Subjects were not allowed to eat or drink anything but the foods supplied by the Institute, except for tap water and coffee. The compliance was good, as indicated by the daily returned questionnaires. Daily energy requirement was estimated for each subject according to Scho®eld (1985) . We considered the energy provided by alcohol to be 19.6 kJ (4.7 kcal) per gram, assuming the net utilizable energy content of alcohol is 70% of the theoretically present 28 kJ (7 kcal) per gram (Rumpler et al, 1996; Westerterp, 1996) . The mean energy intake was 11.4 MJ (2.7 Mcal), range 10.5 ± 12.2 MJ, and did not differ between the four treatments. Forty grams of alcohol per day thus provided on average 7% of the daily energy. The nonalcohol energy of this standard Dutch diet consisted of 11% protein, 36% fat and 53% carbohydrates. Diet was controlled (equal for all treatments) for intake of ascorbic acid, a-tocopherol, a-carotene, b-carotene and¯avonoids, based on available food composition data. As treatment effects of the alcoholic beverages might be caused by beveragespeci®c components other than alcohol, the non-macronutrient composition of the test-beverages was neglected in composing the controlled diet. Evening dinner consisted of a standard amount of soup (instant soup powder in hot water), potatoes, vegetables (peas and carrots, runner beans, string beans; alternately) minced meat and gravy, and fruit yoghurt.
Compliance to the protocol was checked by a daily questionnaire. Body weight was determined twice weekly. When a subject's body weight deviated more than 1.5 kg from his weight at the ®rst experimental day, energy supply was adjusted (plus or minus 1 MJ (0.24 Mcal)), without changing macronutrient composition, in order to maintain body weight.
The study was performed according to the ICH Guideline for Good Clinical Practice (Anonymous, 1995) , and was approved by the Medical Ethics Committee of the Institute.
Blood collection and sample preparation Every 3 weeks blood samples were collected from fasting subjects, in the morning (which was approximately 13 h after the last dinner of each treatment). Blood was taken from the intermedian cubital vein and collected in tubes containing gel and clot activator (Becton Dickinson, Vacutainer Systems) for determination of antioxidant capacity and uric acid concentration, and in ice-chilled tubes containing lithium heparin (Becton Dickinson, Vacutainer Systems) for the remaining determinations. The lithium heparin tubes were directly stored in a closed box after ®lling, to avoid breakdown of the carotenoids by UV light. To obtain serum, the blood was centrifuged for 20 min at 2000 g and 4
C, approximately 30 min after collection. Serum was separated and snap frozen by immersion in liquid nitrogen. The blood containing lithium heparin was centrifuged for 10 min at 2000 g and 4 C, within 30 min of collection. Plasma was separated and directly frozen by use of dry ice. Plasma for vitamin C analysis was mixed with a metaphosphoric acid solution (50 gal; JT Baker, Deventer, Holland) before freezing, to preserve the vitamin C level during storage (Margolis & Duewer, 1996) . The buffy coat and leftover of the plasma were carefully removed from the pellet. Subsequently, the remaining erythrocytes were washed with a physiologic salt solution, diluted with Nonidet, homogenized and put on dry ice. All frozen aliquots were stored at À80 C until analysis. The antioxidant capacity measurements were performed 2 days after sample collection. The remainder of the analyses were performed within 6 months after sample collection.
Antioxidant capacity
The trolox equivalent antioxidant capacity (TEAC) assay was used to analyse in vitro antioxidant capacity in each of the four beverages, as well as in the volunteer's serum. The assay used was originally described by Miller et al (1993) and was adapted according to Van den Berg et al (1999) . Brie¯y, 2,2 H -azinobis-(3-ethylbenzo-thiazoline-6-sulfonate) radical anions (ABTS Á À ) were generated by mixing 2.5 mmolal 2,2 H -azobis-(2-amidinopropane) HCl (ABAP; Polysciences, Warrington, PA) with 20 mmolal ABTS 2À (Sigma, St Louis, MO) stock solution in 100 mmolal PBS (pH 7.4). The solution was heated for 12 min at 60 C, protected from light and stored at room temperature. For measuring antioxidant capacity, 40 ml of the serum was mixed with 1960 ml of the radical solution. Absorbency was monitored at 734 nm for 6 min, using a Pharmacia Ultraspec 4000 spectrophotometer. The decrease in absorption at 734 nm 6 min after addition of beverage or serum was used for calculating the antioxidant capacity, expressed as ( aÀ)-6-hydroxy-2,5,7,8-tetramethyl-chroman-2-carboxylic acid (Trolox) (97%; Aldrich, Milwaukee, WI) equivalents.
Enzyme activities of glutathion peroxidase, glutathion reductase and superoxide dismutase, and uric acid concentration Enzyme activities were all analysed using a Cobas Bio centrifugal analyser (Hoffmann-la Roche, Basle, Switzerland). Serum glutathion peroxidase activity was determined using t-butyl hydroperoxide (Merck, Darmstadt, Germany) as substrate. Erythrocyte glutathion reductase activity was measured using oxidized glutathion (Boehringer, Mannheim, Germany) as substrate. Erythrocyte superoxide dismutase was determined by use of a commercial testkit (Randox, Crumlin, Co. Antrim, UK). Serum uric acid concentration was analysed using a Hitachi 911 automatic analyser (Hitachi Instrument Division, Ibaraki-ken, Japan) by use of a commercial kit (Boehringer, Mannheim, Germany).
Concentrations of ascorbic acid, tocopherols and carotenoids
The plasma containing metaphosphoric acid was used for determination of ascorbic acid. First, all ascorbic acid present in the samples was oxidized to dehydro-L-ascorbic acid using ascorbate oxidase (Boehringer, Mannheim, Germany). After condensation with 1,2-diaminobenzeen (Merck, Darmstadt, Germany) to a quinoxaline derivate, the latter compound was separated by reversed-phase HPLC and detected¯uorometrically. After deproteinization by ethanol (JT Baker, Deventer, Holland), carotenoids and tocopherols were extracted from plasma by n-hexane (Merck, Darmstadt, Germany) and subsequently separated by HPLC and detected by UV-absorbance.
Statistics
Data were analysed using the SAS statistical software package (SASaSTAT Version 6, SAS Institute, Cary, NC). The outcome measures were tested for normality and compared by ANOVA, using the general linear model. Only if the overall F-test yielded a signi®cant (a 0.05, 2-sided) treatment effect were differences between treatments tested (paired t-test) for signi®cance. If the outcome measures of the beer, wine and spirits treatments did not differ, the individual values for those three treatments were averaged, compared to water, and referred to as effect of alcohol.
Results
Antioxidant capacity differed considerably between red wine (20.4 mmolal Trolox), beer (9.0 mmolal Trolox), spirits (0.0 mmolal Trolox) and water (0.0 mmolal Trolox), as assessed in the pure beverages. Red wine had about twice the anti-oxidant capacity of beer (standardized on alcohol quantity) and TEAC was not detectable in spirits and water. However, serum antioxidant capacity was similar, after 3 weeks' consumption, for water (1.30 + 0.07 mmolal Trolox), beer (1.34 + 0.06 mmolal Trolox), red wine (1.33 + 0.08 mmolal Trolox) and spirits (1.32 + 0.11 mmolal Trolox), respectively.
The enzyme activities of serum glutathion peroxidase, erythrocyte glutathion reductase and erythrocyte superoxide dismutase were similar after consumption of wine, beer, spirits and water (Table 2) . Also, haemoglobin concentrations did not differ among the treatments (data not shown).
No treatment effects were observed on the plasma levels of lutein, zeaxantin, b-cryptoxantin, lycopene and a-carotene (Table 3) . However, plasma concentration of bcarotene was 13% (P 0.0004) lower after alcohol consumption as compared to water. The observed decreases in b-carotene concentrations were similar for red wine (À15%, P 0.0005), beer (À11%, P 0.010) and spirits (À13%, P 0.003) consumption. Plasma concentrations of a-and g-tocopherol were not affected by alcohol consumption. Plasma ascorbic acid concentrations were decreased after consumption of beer (À15%, P 0.004) and spirits (À12%, P 0.030) as compared to water. Moreover, the ascorbic acid concentration after consumption of red wine was 12% (P 0.013) higher than after beer consumption. The concentration after spirits consumption did not differ from red wine or beer. Consumption of red wine, beer as well as spirits increased serum uric acid concentrations as compared to water consumption, by 9% (P 0.003), 15% (P`0.0001) and 8% (P 0.008), respectively. The concentration of serum uric acid after beer consumption was Moderate consumption of alcohol MS van der Gaag et al higher than after red wine (6%, P 0.01) or spirits (6%, P 0.02) consumption.
Discussion
We have shown that moderate consumption of red wine, beer and spirits with evening dinner for 3 weeks does not affect serum fasting total antioxidant capacity, compared to consumption of mineral water. Also, enzyme activities of superoxide dismutase, glutathion peroxidase and glutathion reductase were not affected. However, moderate alcohol consumption resulted in small changes in speci®c plasma antioxidants. Plasma b-carotene concentrations were decreased by 13% after consumption of red wine, beer and spirits as compared to water consumption. Also, a similar decrease in plasma ascorbic acid was observed after consumption of beer and spirits. The opposite trend was found for serum levels of uric acid; an increase was observed after consumption of beer and to a lesser extent also after red wine and spirits consumption. In many investigations alcohol is supplied in the fasting state. We supplied the alcoholic beverages with evening dinner, as this better represents a habitual pattern of moderate alcohol intake in The Netherlands. Measurements, however, were performed on fasting samples, which were collected 13 h after every 3 weeks' beverage consumption, so these measurements are indicative of the steady-state antioxidant effects of chronic consumption of red wine, beer and spirits. This is important because associations between antioxidant markers and diseasestate as observed in prospective studies are usually derived from measurements in fasting samples. Since the study had a balanced cross-over design and was diet-controlled, the observed effects cannot be attributed to carry-over, variation between individuals nor to dietary confounding.
Our observation that serum TEAC was not altered by chronic moderate alcohol consumption is consistent with results of Sharpe et al (1995) , who found no effect of 10 days' red wine, nor white wine consumption on serum TEAC. So, we have shown now that also consumption of a larger daily dose of alcohol (40 g, Sharpe et al: * 21 g) for a longer period does not signi®cantly affect serum TEAC.
Antioxidant capacity has been reported to be increased by¯avonoids, and is increased directly following ingestion of red wine. Relatively high peak plasma levels of quercetin, the predominant¯avonoid in red wine, occur within 1 ± 4 h after consumption of¯avonol rich foods (Hollman et al, 1997) . This might explain the increased plasma antioxidant capacity directly following ingestion of red wine as reported by many Maxwell et al, 1994; Whitehead et al, 1995) , and also agrees with the ®nding that alcohol-free red wine increases plasma antioxidant capacity (measured as total radical-trapping antioxidant parameter, TRAP) 50 min after ingestion and returns to baseline again 70 min later (Sera®ni et al, 1998) . The TEAC of the red wine we used is in accordance with published antioxidant values of red wine (Verhagen et al, 1996; Campos & Eduardo, 1996) . However, we did not observe a signi®cant antioxidant contribution of red wine in vivo, possibly because red wine is a relatively poor source of bioavailable¯avonoids (De Vries, 1998) , resulting in negligible contribution to overall antioxidant capacity in fasting serum samples.
The decrease in plasma ascorbic acid concentration, as seen after beer and spirits was not found by Guilland et al (1994) in a cross-sectional study in a healthy, drinking population. However, cross-sectional studies are prone to (dietary) confounding. Wine drinkers tend to have a diet high in antioxidants, particularly high in vitamin C (Mannisto et al, 1997), and wine drinking is associated with a higher intake of fruit and vegetables compared to other alcoholic drinks (Tjùnneland et al, 1999) . Our results are not affected by other factors in their diet than the tested beverage, as we exposed the subjects to a strict diet controlled regime. Our results suggest that alcohol intake, at least for beer and spirits, stimulates the metabolic vitamin C consumption. The absence of this effect after red wine consumption might be due to a counteracting action of the wine polyphenols directly following ingestion. Vitamin C de®ciency is suggested as a risk factor for CHD risk. Nevertheless, as long as dietary vitamin C intake is adequate, the lower plasma levels of vitamin C may be not very meaningful for disease risk (Gey, 1995; Jacob, 1998) .
Our ®nding that serum uric acid concentration was raised by chronic moderate alcohol consumption is consistent with epidemiological literature (Freedman et al, 1995; Wannamethee et al, 1997) and experimental data (Faller & Fox, 1984) . The higher serum concentration of uric acid after consumption of beer as compared to wine and spirits Moderate consumption of alcohol MS van der Gaag et al consumption may result from the relatively high purine content of beer (Gibson et al, 1984) . Uric acid inhibits LDL oxidation in vitro (Schlotte et al, 1998) and also may stabilize plasma vitamin C (Sevanian et al, 1991) . Paradoxically, serum uric acid concentration is suggested to be positively associated with CHD risk (Freedman et al, 1995) and with carotid intimal-medial thickness (Iribarren et al, 1996a) . However in a multivariate analysis the latter association disappeared, suggesting that uric acid may be associated with risk factors for atherosclerosis but is not one itself (Iribarren et al, 1996a) . Furthermore, Iribarren et al, (1996b) found a positive association between CHD and urate among alcohol abstainers, but not among drinkers, suggesting the uric acid raising effect of alcohol does not increase CHD-risk. Uric acid and to a lesser extent vitamin C are important contributors to serum TEAC . Based on the observed changes in plasma concentrations of vitamin C and uric acid and their contribution to serum TEAC and assuming no changes in the other contributors to serum TEAC, an increase in TEAC of 2 ± 3% would be expected after consumption of the alcoholic beverages. Indeed, we observed 2 ± 3% higher TEACvalues after alcohol consumption, which was, however, below the statistical power of our study (a 0.05, p 0.80, d 6%).
The decrease in plasma b-carotenoids by alcohol as we observed is consistent with results from cross-sectional studies (Tsubono et al, 1996; Kitamura et al, 1997; Lecomte et al, 1994b) . Results from intervention studies are inconsistent. Suzukawa et al (1994) observed a 20% decrease in plasma b-carotene levels after 3 weeks' intake of brandy (0.5 g alcoholakg body weight) in male volunteers. However, Forman et al (1995) found an 13% increase in plasma concentration by alcohol consumption (30 gaday) in a 6 month diet-controlled intervention study in premenopausal women. Ingestion of red wine decreases postprandial plasma carotenoid concentrations (Paiva et al, 1998) . So the effects of alcohol on carotenoid levels seem to vary by dose and pattern of alcohol consumption as well as the population studied. We did not observe alcohol effects on other carotenoids measured, suggesting that b-carotene is more vulnerable than the other carotenoids for metabolic interference by alcohol. b-Carotene and total carotenoids levels are inversely associated with CHD risk, so far as such an association exists (Kritchevsky, 1999) . The decrease in b-carotene level by moderate alcohol consumption, therefore, would rather increase than decrease CHD risk in moderate drinkers.
We did not observe alcohol effects on plasma tocopherols. Cross-sectional data are con¯icting, seeing no difference (Guilland et al, 1994) or increased plasma a-tocopherol levels in moderate alcohol consumers (Simonetti et al, 1993; Lecomte et al, 1994a ) in comparison to low or non drinkers. In intervention studies no effect was observed after brandy consumption (Suzakawa et al, 1994) , whereas consumption of Maccabee beer for 30 days was shown to increase plasma total and a-tocopherol (Gorrinstein et al, 1997). The latter ®nding, as suggested by the authors, may be a consequence of the high epicatechin (125 mgal) content of the Maccabee beer. The absence of effects by moderate drinking on serum glutathion peroxidase and erythrocyte glutathion reductase and erythrocyte superoxide dismutase is in accordance with literature (Lecomte et al, 1994a) .
Overall, the differences in effect between the alcoholic beverages were small. This seems consistent with the conclusion of Rimm et al (1996) , based on an extensive review, that the inverse association between moderate alcohol intake and coronary heart disease is similar for wine, beer and spirits. Besides the possible health effects of the decreases in plasma levels of ascorbic acid and bcarotene and increase in uric acid by moderate alcohol consumption, this observation has important implications for epidemiological studies and clinical trials. If associations of ascorbic acid, b-carotene or uric acid with disease or disease bio-markers are being evaluated, one should always take into account the alcohol intake of the subjects.
We conclude that chronic moderate alcohol consumption has small, counteracting effects on plasma antioxidant components, resulting in no signi®cant effect on overall antioxidant status. However, as we measured total serum antioxidant capacity, our work does not exclude the possibility that other antioxidant parameters, such as low density lipoprotein antioxidant capacity, might be affected. The effects on the antioxidant parameters measured are largely independent of the type of alcoholic beverage, and are unlikely to contribute signi®cantly to the (reduced) coronary heart disease risk in moderate drinkers.
